File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force

TitleGood Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force
Authors
Keywordsevidence-informed priority setting
good practices
guidelines
HTA
Issue Date2025
Citation
Value in Health, 2025, v. 28, n. 1, p. 1-15 How to Cite?
AbstractObjectives: Health technology assessment (HTA) guidelines are intended to support successful implementation of HTA by enhancing consistency and transparency in concepts, methods, process, and use, thereby enhancing the legitimacy of the decision-making process. This report lays out good practices and practical recommendations for developing or updating HTA guidelines to ensure successful implementation. Methods: The task force was established in 2022 and comprised experts and academics from various geographical regions, each with substantial experience in developing HTA guidelines for national health policymaking. Literature reviews and key-informant interviews were conducted to inform these good practices. Stakeholder consultations, open peer reviews, and expert opinions validated the recommendations. A series of teleconferences among task force members was held to iteratively refine the report. Results: The recommendations cover 6 key aspects throughout the guideline development cycle: (1) setting objectives, scope, and principles of the guideline, (2) building a team for a quality guideline, (3) defining a stakeholder engagement plan, (iv) developing content and utilizing available resources, (v) putting in place appropriate institutional arrangements, and (vi) monitoring and evaluating guideline success. Conclusion: This report presents a set of resources and context-appropriate practices for developing or updating HTA guidelines. Across all contexts, the recommendations emphasize transparency, building trust among stakeholders, and fostering a culture of ongoing learning and improvement. The report recommends timing development and revision of guidelines according to the HTA landscape and pace of HTA institutionalization. Because HTA is increasingly used to inform different kinds of decision making in a variety of country contexts, it will be important to continue to monitor lessons learned to ensure the recommendations remain relevant and effective.
Persistent Identifierhttp://hdl.handle.net/10722/356345
ISSN
2023 Impact Factor: 4.9
2023 SCImago Journal Rankings: 1.507
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorBotwright, Siobhan-
dc.contributor.authorSittimart, Manit-
dc.contributor.authorChavarina, Kinanti Khansa-
dc.contributor.authorBayani, Diana Beatriz-
dc.contributor.authorMerlin, Tracy-
dc.contributor.authorSurgey, Gavin-
dc.contributor.authorSuharlim, Christian-
dc.contributor.authorEspinoza, Manuel A.-
dc.contributor.authorCulyer, Anthony J.-
dc.contributor.authorOortwijn, Wija-
dc.contributor.authorTeerawattananon, Yot-
dc.date.accessioned2025-05-27T07:22:18Z-
dc.date.available2025-05-27T07:22:18Z-
dc.date.issued2025-
dc.identifier.citationValue in Health, 2025, v. 28, n. 1, p. 1-15-
dc.identifier.issn1098-3015-
dc.identifier.urihttp://hdl.handle.net/10722/356345-
dc.description.abstractObjectives: Health technology assessment (HTA) guidelines are intended to support successful implementation of HTA by enhancing consistency and transparency in concepts, methods, process, and use, thereby enhancing the legitimacy of the decision-making process. This report lays out good practices and practical recommendations for developing or updating HTA guidelines to ensure successful implementation. Methods: The task force was established in 2022 and comprised experts and academics from various geographical regions, each with substantial experience in developing HTA guidelines for national health policymaking. Literature reviews and key-informant interviews were conducted to inform these good practices. Stakeholder consultations, open peer reviews, and expert opinions validated the recommendations. A series of teleconferences among task force members was held to iteratively refine the report. Results: The recommendations cover 6 key aspects throughout the guideline development cycle: (1) setting objectives, scope, and principles of the guideline, (2) building a team for a quality guideline, (3) defining a stakeholder engagement plan, (iv) developing content and utilizing available resources, (v) putting in place appropriate institutional arrangements, and (vi) monitoring and evaluating guideline success. Conclusion: This report presents a set of resources and context-appropriate practices for developing or updating HTA guidelines. Across all contexts, the recommendations emphasize transparency, building trust among stakeholders, and fostering a culture of ongoing learning and improvement. The report recommends timing development and revision of guidelines according to the HTA landscape and pace of HTA institutionalization. Because HTA is increasingly used to inform different kinds of decision making in a variety of country contexts, it will be important to continue to monitor lessons learned to ensure the recommendations remain relevant and effective.-
dc.languageeng-
dc.relation.ispartofValue in Health-
dc.subjectevidence-informed priority setting-
dc.subjectgood practices-
dc.subjectguidelines-
dc.subjectHTA-
dc.titleGood Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.jval.2024.09.001-
dc.identifier.scopuseid_2-s2.0-85214132340-
dc.identifier.volume28-
dc.identifier.issue1-
dc.identifier.spage1-
dc.identifier.epage15-
dc.identifier.eissn1524-4733-
dc.identifier.isiWOS:001415393400001-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats